Impact BioMedical Inc (AMEX:IBO)’s traded shares stood at 21.38 million during the last session. At the close of trading, the stock’s price was $2.08, to imply an increase of 292.45% or $1.55 in intraday trading. The IBO share’s 52-week high remains $3.25, putting it -56.25% down since that peak but still an impressive 75.48% since price per share fell to its 52-week low of $0.51. The company has a valuation of $23.92M, with an average of 2.87 million shares in intraday trading volume over the past 10 days and average of 27.25K shares over the past 3 months.
Impact BioMedical Inc (AMEX:IBO) trade information
After registering a 292.45% upside in the last session, Impact BioMedical Inc (IBO) has traded red over the past five days. The 5-day price performance for the stock is 210.36%, and 4.00% over 30 days. With these gigs, the year-to-date price performance is 43.45%. Short interest in Impact BioMedical Inc (AMEX:IBO) saw shorts transact 12105.0 shares and set a 0.41 days time to cover.
IBO Dividends
Impact BioMedical Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Impact BioMedical Inc (AMEX:IBO)’s Major holders
Impact BioMedical Inc insiders hold 55.16% of total outstanding shares, with institutional holders owning 1.89% of the shares at 4.22% float percentage. In total, 1.89% institutions holds shares in the company.
We also have Fidelity Total Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Impact BioMedical Inc (IBO) shares. Going by data provided on Dec 31, 2024 , Fidelity Total Market Index Fund holds roughly 2.45 shares. This is just over 0.00% of the total shares, with a market valuation of $5093.0. Data from the same date shows that the other fund manager holds a little less at 10.77, or 0.00% of the shares, all valued at about 22397.0.
